Skip to content

Drug interactions

Eluxadoline + Glibenclamide

Severity: Moderate

Eluxadoline and Glibenclamide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Glyburide inhibits OATP1B1, which can raise eluxadoline exposure. Increased eluxadoline levels may cause more adverse effects, such as constipation, pancreatitis and sphincter of Oddi spasm.

What this interaction means in plain words

Eluxadoline and Glibenclamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eluxadoline belongs to Gastrointestinal Tract; Glibenclamide belongs to Endocrine.

Evidence level: Low

Why it happens

Inhibition of OATP1B1-mediated hepatic uptake reduces eluxadoline clearance.

What to do

Use the reduced eluxadoline dose of 75 mg twice daily recommended with OATP1B1 inhibitors. Monitor for abdominal pain and constipation.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eluxadoline and Glibenclamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eluxadoline with Glibenclamide?

MediHelp rates the interaction as moderate. Eluxadoline and Glibenclamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Glyburide inhibits OATP1B1, which can raise eluxadoline exposure. Increased eluxadoline levels may cause more adverse effects, such as constipation, pancreatitis and sphincter of Oddi spasm.

How serious is the interaction between Eluxadoline and Glibenclamide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use the reduced eluxadoline dose of 75 mg twice daily recommended with OATP1B1 inhibitors. Monitor for abdominal pain and constipation.

What other medicines interact with Glibenclamide?

MediHelp also lists interactions of Glibenclamide with, for example, Bosentan, Cholic acid, Ciprofloxacin. The full list is on the Glibenclamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in